Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES)

Peer Review reports

Original Submission
28 Oct 2011	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
Resubmission - Version 4
	Submitted	Manuscript version 4
16 Jan 2012	Author responded	Author comments - Marissa Lassere
Resubmission - Version 5
16 Jan 2012	Submitted	Manuscript version 5
Publishing
12 Mar 2012	Editorially accepted
12 Mar 2012	Article published	10.1186/1471-2288-12-27

Back to article page